Article Information
History
- July 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- James A Watsona,b,c,*,
- Cintia Cruzb,d,
- Fabiana Barreirae,
- Colin Forsythf,
- Alejandro Schijmang,
- Rhys Peploea,b,
- Frauke Assmusb,d,
- Caitlin Naylora,b,
- Jennifer Leea,b,
- Somya Mehrab,d,
- Joel Tarningb,d,
- Faustino Torricoh,
- Joaquim Gasconi,j,
- Lourdes Ortizf,
- Isabela Ribeirof,
- Sergio Sosa-Estanie,
- Craig Tipplef,
- Stéphane Hugonnete,
- Philippe J Guérina,b,
- Laurent Fraissef,
- Maria-Jesus Pinazoe,j,
- Nicholas J Whiteb,d,* and
- the E1224 and BENDITA study groups
- aInfectious Diseases Data Observatory, Oxford, UK
- bCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, United Kingdom
- cOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- dMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand
- eDrugs for Neglected Diseases initiative LATAM, Rio de Janeiro, Brasil
- fDrugs for Neglected Diseases initiative, Geneva, Switzerland
- gInstituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr Hector Torres, CONICET, Laboratorio de Biología Molecular de la Enfermedad de Chagas, Ciudad de Buenos Aires, Argentina
- hFundación Ciencia y Estudios Aplicados para el Desarrollo en Salud y Medio Ambiente (CEADES), Cochabamba, Bolivia
- iBarcelona Institute for Global Health, Barcelona, Spain
- jCIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Spain
- ↵*For correspondence: jwatowatson{at}gmail.com; nickw{at}tropmedres.ac
Posted July 15, 2024.
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials
